Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152281 · ClinicalTrials.gov registry record · Phase 2
Selective Exposure in HIV Prevention
A Phase 2 study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- Phase 2
- Development phase
- 722
- Enrollment target
NCT01152281 is a Phase 2 study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 722 participants.
The verdict
NCT01152281, a Phase 2 study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 722 participants
- Enrollment target
Study Summary
Unfortunately, people most at risk for HIV are the least likely to enroll and remain in prevention programs. In our past work, we have learned how to increase enrollment in such programs among this group. We have identified and addressed previously ignored gender-specific and client self-validation issues that conventional interventions often leave not only uncontrolled, but often biased against participation. The present work will extend these methods from enrollment to retention. We intend to recruit a sample of 656 at-risk participants through our collaboration with the Duval County, FL Health Department for our randomized, double-blind trial. Our study will investigate if a meta-intervention video designed for empowering participants as agents of their own change can increase the number of attended sessions relative to a control condition without such a video. This trial will also determine if a meta-intervention video addressing various emotional/social and instrumental benefits of an HIV-prevention-counseling intervention can also increase the number of attended sessions. These two factors will be crossed, and their effects on retention will be estimated for different genders and ethnicities. Effects on clients' attention to the return sessions as reported by the counselor will also be explored among participants who return. We will also conduct mediator analyses for investigating if the meta-intervention has mediating influences on corresponding expectations about the return counseling session. As the inclusion of meta-cognitive measures can alter the efficacy of the intervention, half of the sample will receive measures immediately (0-10 minutes) after exposure to the meta-intervention, before attendance to the next session is registered. The other half will not complete these measures.
Interventions
- BEHAVIORAL Maximal Control
- BEHAVIORAL Instrumental and Empowering
- BEHAVIORAL Minimal Control
- BEHAVIORAL Instrumental
- BEHAVIORAL Empowering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 722 participants |
| Start Date | 2010-05 |
| Est. Completion | 2017-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152281
The ClinicalTrials.gov registry entry for NCT01152281 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 722 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Maximal Control is the first listed.
NCT01152281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01152281 about?
NCT01152281 is a clinical study titled "Selective Exposure in HIV Prevention". Unfortunately, people most at risk for HIV are the least likely to enroll and remain in prevention programs. In our past work, we have learned how to increase enrollment in such programs among this group. We have identified and addressed previously ignored gender-specific and client self-validation ...
What is the current status of trial NCT01152281?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 722 participants. The study started on 2010-05. Estimated completion is 2017-04-30.
What interventions are being tested in trial NCT01152281?
The interventions under investigation include: Maximal Control (BEHAVIORAL), Instrumental and Empowering (BEHAVIORAL), Minimal Control (BEHAVIORAL), Instrumental (BEHAVIORAL), Empowering (BEHAVIORAL).
Who is sponsoring clinical trial NCT01152281?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.